Clinical trial Recruiting at 1 site Observational Ages 75 and up

Observational study of elderly patients with heart attacks

Official title: Hospital Registry of Patients with Myocardial Infarction in Individuals Aged 75 Years and Older

Run by Ryazan State Medical University · NCT06860646 · Data updated 2026-11-12

This study looks at older patients who have had heart attacks to see how their age affects their treatment and recovery.

Quick facts

Study typeObservational
Ages75 Years and up
SexAll
Enrollment1000 (estimated)
SponsorRyazan State Medical University
Academic / other
Locations1 site (Ryazan)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedSeptember 2028
Study endsDecember 2030
Registry record updatedMarch 6, 2025
Trial IDNCT06860646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 75 years and older with a confirmed diagnosis of myocardial infarction.

Probably not a fit

Patients younger than 75 years or those without a diagnosis of myocardial infarction will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry study focuses on patients aged 75 years and older who have been diagnosed with myocardial infarction. It aims to collect and analyze clinical, instrumental, demographic, and prognostic data to better understand the outcomes and characteristics of this age group. The study began in 2020 and employs statistical analysis to identify significant differences in the collected data. The findings may provide insights into the management of myocardial infarction in elderly patients.

Why it matters

Potential benefit: If successful, this study could enhance understanding of myocardial infarction in elderly patients, leading to improved treatment strategies.

How similar studies have gone: While there may be other studies on myocardial infarction, this specific focus on elderly patients is relatively novel and underexplored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization.

Exclusion Criteria:

\-

Where it's running

  • State Budgetary Institution of the Ryazan Region "Regional Clinical Cardiology Dispensary"
    Ryazan, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Risk of malignant arrhythmias after acute coronary syndrome

    This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

    Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

  • Smartphone AI help for prehospital ECG readings

    This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.

    Recruiting École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care · Murten/Morat, Canton of Fribourg · NCT07810686

  • Optimal timing of staged complete revascularization in STEMI with multivessel disease

    This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.

    Recruiting Chonnam National University Hospital · Bucheon-si and 29 other locations · NCT07741721

  • BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

    This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.

    Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07643610

  • Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells

    Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.

    Recruiting at 2 sites Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire and 1 other locations · NCT07610538

  • Abbreviated antithrombotic therapy after PCI in AF and MI

    This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.

    Recruiting Chonnam National University Hospital · Gwangju, Gwangju · NCT07583784

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.